Our Services
Medical Information
Helpful Resources
Published on: 9/29/2026
Sundowning, the late-day confusion, agitation, pacing, and restlessness linked to dementia, most commonly emerges in the middle (moderate) stage and can persist into the late stage, though some people notice earlier hints. Frequent triggers include end-of-day fatigue, a disrupted internal body clock, fading light and shadows, hunger, pain, infection, and too much noise or activity. Evening strategies that tend to help include a predictable daily routine, bright light exposure earlier in the day, limiting late caffeine and long afternoon naps, keeping rooms well lit at dusk, offering calm and simple activities, and ruling out medical causes such as urinary tract infection or medication side effects. There are several important factors to consider, including how fast symptoms have progressed and which treatable conditions can mimic dementia, so see below for the full details before deciding what to do next. Because evening confusion can signal anything from sleep disruption to infection to a progressing condition, it is worth taking a few minutes for a free, instant, online symptom check to better understand the likely causes and get clear guidance on the right next step for you or your loved one.
Last reviewed for medical accuracy: 09/29/2025
Sundowning refers to a pattern of increased confusion, agitation, restlessness or aggression that typically begins in the late afternoon or early evening. Many caregivers and families ask: what stage of dementia is sundowning most likely to appear? Understanding when sundowning emerges and how to manage it can help you create calmer, more predictable evenings for someone living with dementia.
Dementia progresses through several stages, from mild memory lapses to severe cognitive decline. The Global Deterioration Scale (GDS) or the seven-stage staging system for Alzheimer’s disease is often used:
Several factors contribute to sundowning:
Understanding these triggers helps you anticipate and reduce evening distress.
Watch for these common indicators in the late afternoon or early evening:
Early recognition allows for timely interventions to ease agitation and improve comfort.
Creating a calm, predictable environment can lessen sundowning episodes. Consider these evidence-based approaches:
If sundowning:
…then it’s time to consult a healthcare professional. You might also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to better understand any new or worsening symptoms.
Supporting someone with sundowning can be emotionally and physically draining. To maintain your own well-being:
By understanding the timing and triggers of sundowning—and using structured, compassionate strategies—you can make evenings more comfortable and predictable for someone living with dementia. Remember: if anything feels unsafe or life-threatening, seek medical attention immediately.
(References)
* Ginsburg R, Weintraub M. Caffeine in the "sundown syndrome." Report of negative results. J Gerontol. 1976 Jul;31(4):419-20. doi: 10.1093/geronj/31.4.419. PMID: 774004.
* McGaffigan S, Bliwise DL. The treatment of sundowning. A selective review of pharmacological and nonpharmacological studies. Drugs Aging. 1997 Jan;10(1):10-7. doi: 10.2165/00002512-199710010-00002. PMID: 9111704.
* Brusco LI, Fainstein I, Márquez M, Cardinali DP. Effect of melatonin in selected populations of sleep-disturbed patients. Biol Signals Recept. 1999 Jan-Apr;8(1-2):126-31. doi: 10.1159/000014580. PMID: 10085474.
* Monti JM, Cardinali DP. A critical assessment of the melatonin effect on sleep in humans. Biol Signals Recept. 2000 Nov-Dec;9(6):328-39. doi: 10.1159/000014656. PMID: 11025339.
* Skjerve A, Nygaard HA. Improvement in sundowning in dementia with Lewy bodies after treatment with donepezil. Int J Geriatr Psychiatry. 2000 Dec;15(12):1147-51. doi: 10.1002/1099-1166(200012)15:12<1147::aid-gps262>3.0.co;2-l. PMID: 11180473.
* Olde Rikkert MG, Rigaud AS. Melatonin in elderly patients with insomnia. A systematic review. Z Gerontol Geriatr. 2001 Dec;34(6):491-7. doi: 10.1007/s003910170025. PMID: 11828891.
* Arrieta-Cruz I, Pfaff DW. Definition of arousal and mechanistic studies in intact and brain-damaged mice. Ann N Y Acad Sci. 2009 Mar;1157:24-31. doi: 10.1111/j.1749-6632.2008.04118.x. PMID: 19351353.
* Lammers M, Ahmed AIA. Melatonin for sundown syndrome and delirium in dementia: is it effective? J Am Geriatr Soc. 2013 Jun;61(6):1045-1046. doi: 10.1111/jgs.12296. PMID: 23772740.
* McCleery J, Cohen DA, Sharpley AL. Pharmacotherapies for sleep disturbances in dementia. Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3. 2016 Nov 16. PMID: 27851868; PMCID: PMC6464889.
* McCleery J, Sharpley AL. Pharmacotherapies for sleep disturbances in dementia. Cochrane Database Syst Rev. 2020 Nov 15;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub4. 2020 Nov 15. PMID: 33189083; PMCID: PMC8094738.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.